お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
917609

CAR-T細胞療法の世界市場

Global Market Study on CAR T-cell Therapy: The Future of Cancer Treatment

出版日: | 発行: Persistence Market Research | ページ情報: 英文 150 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
CAR-T細胞療法の世界市場
出版日: 2019年11月13日
発行: Persistence Market Research
ページ情報: 英文 150 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界のCAR-T細胞療法市場について調査しており、市場機会、成長および阻害要因、製品タイプ・適応症・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場調査範囲/分類
  • 市場の定義/範囲/制限

第3章 主な成功要因

  • 氷山分析
  • 収益機会分析
  • 親市場分析
  • パイプライン評価
  • CAR-T細胞療法に適格な潜在的人口:地域別
  • 米国・英国の認定治療センターのリスト
  • 主な包摂/排除

第4章 市場需要(売上/規模)の分析および予測

  • 過去の市場分析
  • 現在・今後の市場予測
    • 前年比成長動向分析

第5章 市場の背景

  • マクロ経済要因
    • 医療費の増加
    • 研究を実施するための主要組織としての学界の出現
    • 治療困難な病気の治療法を特定するための共同の取り組みおよびイニシアチブ
  • 予測要因:関連および影響
    • CAR-T細胞療法の可用性の向上
    • CAR-T細胞療法の採用の増加
    • 優れた製品効率
    • 償還シナリオの改善
    • 製薬会社とバイオ製薬会社間の協業
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会分析

第6章 市場分析:製品タイプ別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在・今後の市場分析・予測
    • Yescarta (axicabtagene ciloleucel)
    • Kymriah (tisagenlecleucel)
    • JCAR017(lisocabtagene maraleucel)
    • BB2121
  • 市場の魅力分析

第7章 市場分析:適応症別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在・今後の市場分析・予測
    • 再発の大細胞型B細胞リンパ腫
    • 急性リンパ芽球性白血病(ALL)
    • 多発性骨髄腫
  • 市場の魅力分析

第8章 市場分析:エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在・今後の市場分析・予測
    • 病院
    • がん治療センター
  • 市場の魅力分析

第9章 市場分析:地域別

  • イントロダクション
  • 過去の市場規模
  • 現在の市場分析・予測
    • 北米
    • 欧州
    • 日本
  • 市場の魅力分析:地域別

第10章 北米

  • イントロダクション
  • 過去の市場分析:市場分類法別
  • 市場予測:市場分類法別
    • 国別
    • 製品タイプ別
    • 表示別
    • エンドユーザー別
  • 市場の魅力分析
  • 主要市場参入企業:強度マッピング
  • 成長および阻害要因:影響分析

第11章 欧州

第12章 日本

第13章 市場構造分析

  • 市場分析:企業の階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析
    • 企業の実績:地域別
    • 製品の実績:企業別
    • チャネルの実績:企業別

第14章 競合情勢

  • 競合ダッシュボード
  • 価格分析:競合別
  • 競合ベンチマーク
  • 企業プロファイル
    • Novartis AG
    • Gilead Sciences Inc.
    • Celgene Corporation
    • bluebird bio, Inc.

第15章 前提条件および略語の使用

第16章 調査方法

図表

List of Tables

  • Table 01: CAR T-Cell Therapy, Pipeline Assessment
  • Table 02: CAR T-Cell Therapy, Pipeline Assessment
  • Table 03: CAR T-Cell Therapy, Pipeline Assessment
  • Table 04: CAR T-Cell Therapy, Pipeline Assessment
  • Table 05: CAR T-Cell Therapy, Pipeline Assessment
  • Table 06: CAR T-Cell Therapy, Pipeline Assessment
  • Table 07: CAR T-Cell Therapy, Pipeline Assessment
  • Table 08: CAR T-Cell Therapy, Pipeline Assessment
  • Table 09: CAR T-Cell Therapy, Pipeline Assessment
  • Table 10: CAR T-Cell Therapy, Pipeline Assessment
  • Table 11: CAR T-Cell Therapy, Pipeline Assessment
  • Table 12: CAR T-Cell Therapy, Pipeline Assessment
  • Table 13: CAR T-Cell Therapy, Pipeline Assessment
  • Table 14: CAR T-Cell Therapy, Pipeline Assessment
  • Table 15: CAR T-Cell Therapy, Pipeline Assessment
  • Table 16: CAR T-Cell Therapy, Pipeline Assessment
  • Table 17: CAR T-Cell Therapy, Pipeline Assessment
  • Table 18: CAR T-Cell Therapy, Pipeline Assessment
  • Table 19: CAR T-Cell Therapy, Pipeline Assessment
  • Table 20: CAR T-Cell Therapy, Pipeline Assessment
  • Table 21: CAR T-Cell Therapy, Pipeline Assessment
  • Table 22: CAR T-Cell Therapy, Pipeline Assessment
  • Table 23: CAR T-Cell Therapy, Pipeline Assessment
  • Table 24: CAR T-Cell Therapy, Pipeline Assessment
  • Table 25: CAR T-Cell Therapy, Pipeline Assessment
  • Table 26: CAR T-Cell Therapy, Pipeline Assessment
  • Table 27: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 28: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 29: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 30: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.
  • Table 31: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.K.
  • Table 32: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 33: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 34: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User
  • Table 35: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Region
  • Table 36: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country
  • Table 37: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 38: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 39: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User
  • Table 40: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country
  • Table 41: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 42: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 43: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User
  • Table 44: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type
  • Table 45: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication
  • Table 46: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

List of Figures

  • Figure 01: CAR T-Cell Therapy Market Value ($ Mn), By Country, 2018 & 2026
  • Figure 02: Global CAR T-Cell Therapy Market Value Share By Product Type (2019E)
  • Figure 03: Global CAR T-Cell Therapy Market Value Share By Indication (2019E)
  • Figure 04: Global CAR T-Cell Therapy Market Value Share By End User (2019E)
  • Figure 05: Global CAR T-Cell Therapy Market Value Share By Region (2019E)
  • Figure 06: CAR T-Cell Therapy, Pipeline Assessment
  • Figure 07: Global CAR T-Cell Therapy Market Value Analysis (US$ Mn), 2017-2018
  • Figure 08: Global CAR T-Cell Therapy Market Value Analysis (US$ Mn), 2019-2026
  • Figure 09: Global CAR T-Cell Therapy Market Absolute $ Opportunity, 2017-2018
  • Figure 10: Global CAR T-Cell Therapy Market Absolute $ Opportunity, 2019-2026
  • Figure 11: Global CAR T-Cell Therapy Market Share Analysis (%) By Product Type, 2019 & 2026
  • Figure 12: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Product Type, 2019-2026
  • Figure 13: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 14: Global CAR T-Cell Therapy Market Share Analysis (%) By Indication, 2019 & 2026
  • Figure 15: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Indication, 2019-2026
  • Figure 16: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Indication
  • Figure 17: Global CAR T-Cell Therapy Market Share Analysis (%) By End User, 2019 & 2026
  • Figure 18: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By End User, 2019-2026
  • Figure 19: Global CAR T-Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 20: Global CAR T-Cell Therapy Market Share Analysis (%) By Region, 2019 & 2026
  • Figure 21: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Region, 2019-2026
  • Figure 22: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Region
  • Figure 23: North America CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018
  • Figure 24: North America CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026
  • Figure 25: North America CAR T-Cell Therapy Market Analysis by Country - 2019 & 2026
  • Figure 26: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Country, 2019-2026
  • Figure 27: North America CAR T-Cell Therapy Market Attractiveness Analysis by Country, 2019-2026
  • Figure 28: North America CAR T-Cell Therapy Market Analysis by Product Type - 2019 & 2026
  • Figure 29: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026
  • Figure 30: North America CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026
  • Figure 31: North America CAR T-Cell Therapy Market Analysis by Indication -2019 & 2026
  • Figure 32: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026
  • Figure 33: North America CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026
  • Figure 34: North America CAR T-Cell Therapy Market Analysis by End User -2019 & 2026
  • Figure 35: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026
  • Figure 36: North America CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026
  • Figure 37: Europe CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018
  • Figure 38: Europe CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026
  • Figure 39: Europe CAR T-Cell Therapy Market Analysis by Country - 2019 & 2026
  • Figure 40: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Country, 2019-2026
  • Figure 41: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Country, 2019-2026
  • Figure 42: Europe CAR T-Cell Therapy Market Analysis by Product Type - 2019 & 2026
  • Figure 43: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026
  • Figure 44: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026
  • Figure 45: Europe CAR T-Cell Therapy Market Analysis by Indication -2019 & 2026
  • Figure 46: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026
  • Figure 47: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026
  • Figure 48: Europe CAR T-Cell Therapy Market Analysis by End User -2019 & 2026
  • Figure 49: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026
  • Figure 50: Europe CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026
  • Figure 51: Japan CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018
  • Figure 52: Japan CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026
  • Figure 53: Japan CAR T-Cell Therapy Market Analysis by Product Type - 2019 & 2026
  • Figure 54: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026
  • Figure 55: Japan CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026
  • Figure 56: Japan CAR T-Cell Therapy Market Analysis by Indication -2019 & 2026
  • Figure 57: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026
  • Figure 58: Japan CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026
  • Figure 59: Japan CAR T-Cell Therapy Market Analysis by End User -2019 & 2026
  • Figure 60: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026
  • Figure 61: Japan CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026
  • Figure 62: Company Market Share Analysis, 2018
目次

CAR T-Cell Therapy Market - Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global market for CAR T-cell therapy. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the CAR T-cell therapy market structure. The market study presents exclusive information about how the CAR T-cell therapy market will grow during the forecast period 2019 - 2026.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the CAR T-cell therapy market during the forecast period.

The study is relevant for stakeholders in the CAR T-cell therapy market, including CAR T-cell therapy products manufactures, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the CAR T-cell therapy market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR's study.

The study also includes statistics as well as facts related to macroeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the CAR T-cell therapy market. Furthermore, small businesses and new entrants in the CAR T-cell therapy market too can make use of the information presented in this study, based on, which they can make appropriate business decisions to gain momentum in the CAR T-cell therapy market.

Key Questions Answered in PMR's CAR T-Cell Therapy Market Report

  • Which regions will continue to remain the most profitable regional markets for CAR T-cell therapy market players?
  • Which factors will essentially induce a change in the demand for CAR T-cell therapy in the forecast period?
  • How will changing trends impact the CAR T-cell therapy market?
  • What are key manufacturers' strategy to enhance their product adoption and improve regional product footprints?
  • Which companies are leading the CAR T-cell therapy market?
  • What are the winning strategies of stakeholders in the CAR T-cell therapy market to upscale their position in this landscape?

CAR T-Cell Therapy Market: Research Methodology

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the CAR T-cell therapy market, and reach conclusions on future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.

Secondary resources referred to analysts during the production of the CAR T-cell therapy market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the CAR T-cell therapy market, and makes PMR's projection on the growth prospects of the CAR T-Cell therapy market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Key Market Trends
  • 1.3. Market Share Analysis, By Taxonomy
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Success Factors

  • 3.1. Iceberg Analysis
  • 3.2. Revenue Opportunity Analysis
  • 3.3. Parent Market Analysis
  • 3.4. Pipeline Assessment
  • 3.5. Potential Population Eligible for CAR T-cell Therapy, By Region
  • 3.6. List of Authorized Treatment Centers in the U.S. & U.K.
  • 3.7. Key Inclusion & Exclusion

4. Global CAR T-Cell Therapy Market Demand (in Value or Size in US$ Mn) Analysis 2017-2018 and Forecast, 2019-2026

  • 4.1. Historical Market Value (US$ Mn) Analysis, 2017-2018
  • 4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2026
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Increase in Healthcare Spending
    • 5.1.2. Emergence of Academia as the Primary Organization for Carrying Out Research
    • 5.1.3. Collaborative Efforts and Initiatives to Identify Therapies for Difficult-To-Treat Illnesses
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Availability of CAR T-cell Therapy
    • 5.2.2. Increasing Adoption of CAR T-cell Therapy
    • 5.2.3. Superior Product Efficacy
    • 5.2.4. Improving Reimbursement Scenario
    • 5.2.5. Collaboration among Pharmaceutical and Biopharmaceutical Companies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) and Analysis By Product Type, 2017-2018
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019-2026
    • 6.3.1. Yescarta (axicabtagene ciloleucel)
    • 6.3.2. Kymriah (tisagenlecleucel)
    • 6.3.3. JCAR017 (lisocabtagene maraleucel)
    • 6.3.4. bb2121 Market Attractiveness Analysis By Product Type

7. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Indication

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017-2018
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019-2026
    • 7.3.1. Relapsed Large B-cell Lymphoma
    • 7.3.2. Acute Lymphoblastic Leukemia (ALL)
    • 7.3.3. Multiple Myeloma
  • 7.4. Market Attractiveness Analysis By Indication

8. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by End User

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2026
    • 8.3.1. Hospitals
    • 8.3.2. Cancer Treatment Centers
  • 8.4. Market Attractiveness Analysis By End User

9. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Region

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn Analysis By Region, 2017-2018
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2026
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Japan
  • 9.4. Market Attractiveness Analysis By Region

10. North America CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
  • 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Product Type
    • 10.3.3. By Indication
    • 10.3.4. By End User
  • 10.4. Market Attractiveness Analysis
  • 10.5. Key Market Participants - Intensity Mapping
  • 10.6. Drivers and Restraints - Impact Analysis

11. Europe CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
    • 11.3.1. By Country
      • 11.3.1.1. Germany
      • 11.3.1.2. Italy
      • 11.3.1.3. France
      • 11.3.1.4. U.K.
      • 11.3.1.5. Spain
      • 11.3.1.6. Rest of Europe
    • 11.3.2. By Product Type
    • 11.3.3. By Indication
    • 11.3.4. By End User
  • 11.4. Market Attractiveness Analysis
  • 11.5. Key Market Participants - Intensity Mapping
  • 11.6. Drivers and Restraints - Impact Analysis

12. Japan CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
    • 12.3.1. By Product Type
    • 12.3.2. By Indication
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis

13. Market Structure Analysis

  • 13.1. Market Analysis by Tier of Companies (CAR T-Cell Therapy)
  • 13.2. Market Share Analysis of Top Players
  • 13.3. Market Presence Analysis
    • 13.3.1. By Regional footprint of Players
    • 13.3.2. Treatment foot print by Players
    • 13.3.3. Channel Foot Print by Players

14. Competition Analysis

  • 14.1. Competition Dashboard
  • 14.2. Pricing Analysis by Competition
  • 14.3. Competition Benchmarking
  • 14.4. Competition Deep Dive
    • 14.4.1. Novartis AG
      • 14.4.1.1. Overview
      • 14.4.1.2. Drug Portfolio
      • 14.4.1.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.1.4. Sales Footprint
      • 14.4.1.5. Strategy Overview
        • 14.4.1.5.1. Marketing Strategy
        • 14.4.1.5.2. Drug Strategy
        • 14.4.1.5.3. Channel Strategy
    • 14.4.2. Gilead Sciences Inc.
      • 14.4.2.1. Overview
      • 14.4.2.2. Drug Portfolio
      • 14.4.2.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.2.4. Sales Footprint
      • 14.4.2.5. Strategy Overview
        • 14.4.2.5.1. Marketing Strategy
        • 14.4.2.5.2. Drug Strategy
        • 14.4.2.5.3. Channel Strategy
    • 14.4.3. Celgene Corporation
      • 14.4.3.1. Overview
      • 14.4.3.2. Drug Portfolio
      • 14.4.3.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.3.4. Sales Footprint
      • 14.4.3.5. Strategy Overview
        • 14.4.3.5.1. Marketing Strategy
        • 14.4.3.5.2. Drug Strategy
        • 14.4.3.5.3. Channel Strategy
    • 14.4.4. bluebird bio, Inc.
      • 14.4.4.1. Overview
      • 14.4.4.2. Drug Portfolio
      • 14.4.4.3. Profitability by Market Segments (Drug/Channel/Region)
      • 14.4.4.4. Sales Footprint
      • 14.4.4.5. Strategy Overview
        • 14.4.4.5.1. Marketing Strategy
        • 14.4.4.5.2. Drug Strategy
        • 14.4.4.5.3. Channel Strategy

15. Assumptions and Acronyms Used

16. Research Methodology

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.